Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA | BSE: 524715

Mid-range Performer

Download real time

1620.20 9.70 (0.60%)

Near 52W Low of ₹1553.05

2.4M

NSE+BSE Volume

NSE 17 Sep, 2025 3:31 PM (IST)

Sun Pharmaceutical Industries Ltd. share price target

Sun Pharmaceutical Industries Ltd. has an average share price target of 2050.25. The consensus estimate represents an upside of 26.54% from the last price of 1620.20. View 14 reports from 8 analysts offering long-term price targets for Sun Pharmaceutical Industries Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	18 Sep 2025	Sun Pharmaceutical	Consensus Share Price Target	1620.20	1930.16	-	19.13	buy	pdf Detailed Estimates
	02 Nov 2022	Sun Pharmaceutical	Prabhudas Lilladhar Target	1620.20	1175.00	1044.20 (55.16%)		Buy	pdf post cache		Broker Report SUN PHARMACEUTICAL I Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	ICICI Direct Target	1620.20	1225.00	1051.95 (54.02%)		Buy	pdf post cache		Broker Report Sun Pharma ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	Motilal Oswal Target	1620.20	1240.00	1051.95 (54.02%)		Buy	pdf post cache		Broker Report Another quarter of an earnings beat Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	02 Nov 2022	Sun Pharmaceutical	ICICI Securities Limited Target	1620.20	1002.00	1036.60 (56.30%)	Target met	Hold	pdf post cache		Broker Report Specialty business grows; margins expand ICICI Securities Limited Sun Pharmaceutical’s (Sun) Q2FY23 performance has been better than our estimates. pdf Copy Link Share on Share on Share on Share on Alert
	01 Nov 2022	Sun Pharmaceutical	BOB Capital Markets Ltd. Reco	1620.20	1100.00	1051.95 (54.02%)	Target met	Hold	pdf post cache		Broker Report Sun Pharma (HOLD): Strong Q2 but valuations full cut to HOLD BOB Capital Markets Ltd. Brisk Q2 revenue growth at 14% YoY to Rs 110bn backed by ramp-up in global specialty business and healthy India/EM sales pdf Copy Link Share on Share on Share on Share on Alert
	01 Nov 2022	Sun Pharmaceutical	Bonanza	1620.20	1072.00	1036.60 (56.30%)	Target met	Buy	pdf post cache		Broker Report STRATEGY: TECHNICAL RESULT PREVIEW Q2 FY23 Bonanza Given that there are good chances of breakout on both the sides but down side is normally remained limited in Sun Pharma historically. pdf Copy Link Share on Share on Share on Share on Alert
	05 Aug 2022	Sun Pharmaceutical	Edelweiss Target	1620.20	916.00	915.95 (76.89%)	Target met	Buy	pdf post cache		Broker Report Pick of the Week - Sun Pharmaceutical Industries Ltd. Edelweiss Sun Pharmaceuticals is the largest Indian Pharma company with an impressive track record of organic and inorganic growth. pdf Copy Link Share on Share on Share on Share on Alert
	01 Aug 2022	Sun Pharmaceutical	SMC online	1620.20		897.00 (80.62%)		Results Update	pdf post cache		Broker Report Sun Pharmaceutical Industries SMC online pdf Copy Link Share on Share on Share on Share on Alert
	31 Jul 2022	Sun Pharmaceutical	Prabhudas Lilladhar Target	1620.20	1070.00	918.70 (76.36%)	Target met	Buy	pdf post cache		Broker Report SUN PHARMACEUTICAL I Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	30 Jul 2022	Sun Pharmaceutical	ICICI Direct Target	1620.20	1125.00	943.20 (71.78%)	Target met	Buy	pdf post cache		Broker Report Sun Pharma ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners